australianpompe.com
Pompe | Links
http://australianpompe.com/links
Diet & Exercise. Pompe Newborn Screening Request. Press Release: Government approves lifesaving treatment. Press Release: Children to Receive Treatment. AMDA (Acid Maltase Deficiency Association). Association for Glycogen Storage Disease (UK) Limited. Federal Department of Health. Life Saving Drugs Program. Federal Department of Health. Myozyme Application form and Guidelines. No products in the basket.
ir.amicustherapeutics.com
Investor Relations - Amicus Therapeutics
http://ir.amicustherapeutics.com/index.cfm
Welcome from Chairman and CEO. Posters, Abstracts, and Publications. Patient Advocacy at Amicus. Educational Grants and Charitable Contributions. Annual Reports and Proxies. Sign Up for Email Alerts. A passionate team with a purpose. As a monotherapy for Fabry disease, SD-101. For Epidermolysis Bullosa (EB), as well as novel enzyme replacement therapy (ERT) products for Fabry disease, Pompe disease, and other Lysosomal Storage Disorders. Aug 10, 2016. Aug 9, 2016. View all press releases ». Jul 11, 2016.
epinephrine24seven.wordpress.com
Amicus Study 011 In Fabry Disease Released Today ( $FOLD) | Translating Healthcare
https://epinephrine24seven.wordpress.com/2013/02/15/amicus-study-011-in-fabry-disease-released-today-fold
Life Science and Healthcare News. Amicus Study 011 In Fabry Disease Released Today ( $FOLD). February 15, 2013 in Diseases. Today, Amicus Therapeutics. Will release the full results of its phase 3 study 011 in treating Fabry disease. This study failed to meet its 6 month primary end-point (Kidney GL3 lipid reduction) in December of 2012. Even though this study failed, many, including the CEO Mr. John Crowley. Are optimistic about the drug Migalastat. Is one of many Lysosomal storage diseases:. John Crowl...
ir.amicusrx.com
Corporate Governance - Amicus Therapeutics
http://ir.amicusrx.com/corporate-governance.cfm
Welcome from Chairman and CEO. Epidermolysis Bullosa (EB) Program. Patient Advocacy at Amicus. Grants and Charitable Donations. Annual Reports and Proxies. Sign Up for Email Alerts. Annual Reports and Proxies. Sign Up for Email Alerts. Essential Governance Documents and Committees Charters.
ir.amicusrx.com
SEC Filings - Amicus Therapeutics
http://ir.amicusrx.com/sec.cfm
Welcome from Chairman and CEO. Epidermolysis Bullosa (EB) Program. Patient Advocacy at Amicus. Grants and Charitable Donations. Annual Reports and Proxies. Sign Up for Email Alerts. Annual Reports and Proxies. Sign Up for Email Alerts. All Filings (excluding Section 16). Apr 3, 2017. Mar 13, 2017. Statement of beneficial ownership. Mar 8, 2017. Mar 3, 2017. Campbell, bradley l. Mar 3, 2017. Mar 1, 2017. Mar 1, 2017. Feb 16, 2017. Feb 16, 2017. Feb 15, 2017. 10 results per page. 25 results per page.
ir.amicusrx.com
Events & Presentations - Amicus Therapeutics
http://ir.amicusrx.com/events.cfm
Welcome from Chairman and CEO. Epidermolysis Bullosa (EB) Program. Patient Advocacy at Amicus. Grants and Charitable Donations. Annual Reports and Proxies. Sign Up for Email Alerts. Annual Reports and Proxies. Sign Up for Email Alerts. Corporate Overview April 2017. Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. Mar 14, 2017. Barclays Global Healthcare Conference 2017. Mar 8, 2017. Cowen and Company 37th Annual Health Care Conference. Amicus Th...
ir.amicusrx.com
Annual Reports and Proxies - Amicus Therapeutics
http://ir.amicusrx.com/annuals-proxies.cfm
Welcome from Chairman and CEO. Epidermolysis Bullosa (EB) Program. Patient Advocacy at Amicus. Grants and Charitable Donations. Annual Reports and Proxies. Sign Up for Email Alerts. Annual Reports and Proxies. Sign Up for Email Alerts. Annual Reports and Proxies.
ir.amicusrx.com
Stock Performance - Amicus Therapeutics
http://ir.amicusrx.com/stockquote.cfm
Welcome from Chairman and CEO. Epidermolysis Bullosa (EB) Program. Patient Advocacy at Amicus. Grants and Charitable Donations. Annual Reports and Proxies. Sign Up for Email Alerts. Annual Reports and Proxies. Sign Up for Email Alerts. 4:00 PM ET on Apr 21, 2017. Sign up for email alerts.
